RA0083

antibody from Oursmab

Targeting: CD276 B7-H3, B7H3, B7RP-2

Western blot (Supportive data in Antibodypedia)

ELISA (Data presented on provider website)

Immunocytochemistry (Recommended by provider)

Flow cytometry (Recommended by provider)

Functional assay (Recommended by provider)

Antibody Data

Product number

RA0083

Provider

Oursmab

Product name

Ifinatamab (Biosimilar Reference Antibody) (CD276)

Antibody type

Monoclonal

Description

Ifinatamab deruxtecan (I-DXd) is an investigational antibody-drug conjugate (ADC) targeting the B7-H3 protein, used in advanced cancers like small cell lung cancer (SCLC) and prostate cancer, showing promising response rates in Phase 2 trials, though it carries risks like fatigue, low blood counts, and lung issues, and is under development by Daiichi Sankyo & Merck.

Reactivity

Human

Isotype

IgG

Vial size

100 ¦Ìg,1 mg,5 mg,10 mg,25 mg,50 mg,100 mg

Concentration

Bottled at the concentration indicated on the vial.

Storage

Store at -20¡ãC or -80¡ãC. Avoid repeated freeze.

Western blot

Supportive validation

Submitted by

Oursmab (provider)

Main image

Experimental details

Ifinatamab (Biosimilar Reference Antibody) (CD276)-RA0083-Oursmab determined by SDS-PAGE. The purity of the protein is greater than 98%.